{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:04:45Z","timestamp":1791493485191,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jbspin.2015.07.002","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T08:51:37Z","timestamp":1443775897000},"page":"330-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Anti-pseudo-PCNA type 1 (anti-SG2NA) pattern: Track down Cancer, not SLE"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0615-5305","authenticated-orcid":false,"given":"Aur\u00e9lien","family":"Guffroy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8743-3236","authenticated-orcid":false,"given":"Alina","family":"Dima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Nespola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Poindron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Sibilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Herbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"De S\u00e8ze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Habersetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Andres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Quoix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cribier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Goetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Korganow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2015.07.002_bib0105","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/ard.2009.127100","article-title":"ANA screening: an old test with new recommendations","volume":"69","author":"Meroni","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0110","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/ard.60.12.1131","article-title":"Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing","volume":"60","author":"Peene","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0115","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaut.2010.06.019","article-title":"Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells","volume":"35","author":"Wiik","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0120","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.4049\/jimmunol.121.6.2228","article-title":"Autoantibody to a nuclear antigen in proliferating cells","volume":"121","author":"Miyachi","year":"1978","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0125","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1242\/jcs.00653","article-title":"Proliferating cell nuclear antigen (PCNA): a dancer with many partners","volume":"116","author":"Maga","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0130","first-page":"241","article-title":"Autoantibody to proliferating cell nuclear antigen (PCNA) in SLE: a clinical and serological study","volume":"5","author":"Asero","year":"1987","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0135","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jbspin.2004.11.005","article-title":"Anti-PCNA antibodies: prevalence and predictive value","volume":"72","author":"Beyne-Rauzy","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0140","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1177\/0961203310375265","article-title":"Novel diagnostic and clinical aspects of anti-PCNA antibodies detected by novel detection methods","volume":"19","author":"Mahler","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0145","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.autrev.2013.03.014","article-title":"Prevalence and clinical significance of rare antinuclear antibody patterns","volume":"12","author":"Vermeersch","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0150","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1136\/ard.2008.104190","article-title":"Antinuclear antibodies directed against proliferating cell nuclear antigen are not specifically associated with systemic lupus erythematosus","volume":"68","author":"Vermeersch","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/10428199709058337","article-title":"Detection of proliferating cell nuclear antigen (PCNA) in peripheral blood mononuclear cells and sera of patients with malignant lymphoma","volume":"28","author":"Takahashi","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0160","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ard.58.10.630","article-title":"Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection","volume":"58","author":"Tzang","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/excr.1994.1141","article-title":"Characterization of a DNA-binding nuclear autoantigen mainly associated with S phase and G2 cells","volume":"212","author":"Landberg","year":"1994","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0170","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1006\/bbrc.1995.1288","article-title":"A cell-cycle nuclear autoantigen containing WD-40 motifs expressed mainly in S and G2 phase cells","volume":"207","author":"Muro","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0175","series-title":"Auto-anticorps et maladies auto-immunes.","first-page":"978","author":"Humbel","year":"2000"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0180","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1074\/jbc.275.8.5257","article-title":"WD40 repeat proteins striatin and S\/G(2) nuclear autoantigen are members of a novel family of calmodulin-binding proteins that associate with protein phosphatase 2A","volume":"275","author":"Moreno","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0185","first-page":"1","article-title":"Among the three striatin family members, SG2NA was first to arise during evolution","volume":"6","author":"Tanti","year":"2014","journal-title":"Front Biosci Sch Ed"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0190","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/art.1780400909","article-title":"Range of antinuclear antibodies in \u2018healthy\u2019 individuals","volume":"40","author":"Tan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0195","series-title":"Atlas of HEp-2 patterns","author":"Bradwell","year":"2007"},{"key":"10.1016\/j.jbspin.2015.07.002_bib0200","series-title":"From the most common to the rarest on Hep-2 slides","author":"Humbel","year":"2011"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15001517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X15001517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T21:35:56Z","timestamp":1692048956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X15001517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1297319X15001517"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.07.002","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-pseudo-PCNA type 1 (anti-SG2NA) pattern: Track down Cancer, not SLE","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2015.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}